Utilizing Pharmacogenomics Results to Determine Opioid Appropriateness and Improve Pain Management in a Patient with Osteoarthritis

The opioid epidemic in the United States has exposed the need for providers to limit opioid dispensing and identify at-risk patients prior to prescribing opioids. With pharmacogenomic testing, clinicians can analyze hundreds of medications—including commonly prescribed opioids—against genetic result...

Descripción completa

Detalles Bibliográficos
Autores principales: Pizzolato, Katie, Thacker, David, Del Toro-Pagán, Nicole Marie, Amin, Nishita S, Hanna, Abeer, Turgeon, Jacques, Michaud, Veronique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651068/
https://www.ncbi.nlm.nih.gov/pubmed/36393978
http://dx.doi.org/10.2147/PGPM.S385272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651068/
https://www.ncbi.nlm.nih.gov/pubmed/36393978
http://dx.doi.org/10.2147/PGPM.S385272

Ejemplares similares